Operating Lease, Right-of-Use Asset of Xeris Biopharma Holdings, Inc. from 31 Dec 2021 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Xeris Biopharma Holdings, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2021 to 31 Dec 2025.
  • Xeris Biopharma Holdings, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $22,112,000, a 2.4% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Xeris Biopharma Holdings, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $22,112,000 -$537,000 -2.4% 31 Dec 2025 10-K 02 Mar 2026 2025 FY
Q3 2025 $22,263,000 -$495,000 -2.2% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $22,403,000 -$461,000 -2% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $22,531,000 -$496,000 -2.2% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $22,649,000 -$555,000 -2.4% 31 Dec 2024 10-K 02 Mar 2026 2025 FY
Q3 2024 $22,758,000 -$649,000 -2.8% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $22,864,000 -$768,000 -3.2% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $23,027,000 +$19,141,000 +493% 31 Mar 2024 10-Q 09 May 2024 2024 FY
Q4 2023 $23,204,000 +$19,212,000 +481% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 $23,407,000 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $23,632,000 30 Jun 2023 10-Q 08 Aug 2023 2023 FY
Q1 2023 $3,886,000 31 Mar 2023 10-Q 09 May 2023 2023 FY
Q4 2022 $3,992,000 +$3,992,000 31 Dec 2022 10-K 06 Mar 2024 2023 FY
Q4 2021 $0 31 Dec 2021 10-K 08 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.